Obesity

Study finds people with type 2 diabetes at higher risk of death from both obesity-related and non-obesity related cancers

2018-12-13T12:24:17+00:00

Being overweight or obese may put adults with diabetes at greater risk of dying from cancer than their diabetes-free counterparts, particularly for obesity-related cancers such as those arising from the bowel, kidney, and pancreas in men and women, and from the breast and endometrium (lining of the uterus) in women.

Study finds people with type 2 diabetes at higher risk of death from both obesity-related and non-obesity related cancers2018-12-13T12:24:17+00:00

Chewing gum while walking affects both physical and physiological functions, especially in middle-aged and elderly men

2018-12-13T12:47:15+00:00

New research presented at this year's European Congress on Obesity (ECO) in Vienna, Austria (23-26) May shows chewing gum while walking increases heart rate and energy expenditure.

Chewing gum while walking affects both physical and physiological functions, especially in middle-aged and elderly men2018-12-13T12:47:15+00:00

The obesity paradox: large study finds people hospitalised for infections are twice as likely to survive if they are overweight or obese

2018-12-13T12:52:19+00:00

A study of more than 18,000 patients in Denmark, presented at this year’s European Congress on Obesity in Vienna, Austria (23-26), shows that patients admitted to hospital for treatment for any infectious disease are around twice as likely to survive if they are overweight or obese.

The obesity paradox: large study finds people hospitalised for infections are twice as likely to survive if they are overweight or obese2018-12-13T12:52:19+00:00

On current trends, almost a quarter of people in the world will be obese by 2045, and one in eight will have type 2 diabetes

2018-11-30T14:48:41+00:00

New research from various cities in the world presented at this year's European Congress on Obesity in Vienna, Austria (23-26 May) demonstrate that if current trends continue, almost a quarter (22%) of the people in the world will be obese by 2045 (up from 14% in 2017), and one in eight (12%) will have type 2 diabetes (up from 9% in 2017).

On current trends, almost a quarter of people in the world will be obese by 2045, and one in eight will have type 2 diabetes2018-11-30T14:48:41+00:00

Analysis of new studies including 250,000 people confirms sugar-sweetened drinks are linked to overweight and obesity in children and adults

2018-11-30T14:50:59+00:00

A new review of the latest evidence on sugar-sweetened beverages (SSBs)– which includes 30 new studies published between 2013 and 2015 (and none of them industry sponsored) – concludes that SSB consumption is associated with overweight and obesity, and that countries that have not already done so should take action to reduce the consumption of the so-called ‘empty calories’ that these drinks contain.

Analysis of new studies including 250,000 people confirms sugar-sweetened drinks are linked to overweight and obesity in children and adults2018-11-30T14:50:59+00:00

New device that tackles obesity and diabetes shows promise as NHS treatment

2018-11-30T14:52:30+00:00

The UK's first National Health Service (NHS) service to provide a new, non-surgical, reversible weight loss device for people who have both poorly controlled type 2 diabetes and obesity is safe and effective and should be rolled out across the NHS, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal (11-15 September).

New device that tackles obesity and diabetes shows promise as NHS treatment2018-11-30T14:52:30+00:00

Use of new swallowable gastric balloon results in substantial weight loss

2018-12-03T10:18:19+00:00

New research presented at this year’s European Congress on Obesity (ECO) in Porto, Portugal (17-20 May) shows that a swallowable gastic balloon – that can be inserted without endoscopy or anaesthesia – is a safe and effective way to induce substantial weight loss. The study is by Dr Roberta Ienca, Sapienza University of Rome, Italy, and colleagues.

Use of new swallowable gastric balloon results in substantial weight loss2018-12-03T10:18:19+00:00